Advancement in antithrombotics for stroke prevention in atrial fibrillation (original) (raw)
Another oral thrombin inhibitor for stroke prevention in atrial fibrillation?
Jeffrey Weitz
Thrombosis and Haemostasis, 2010
View PDFchevron_right
Stroke Prevention in Atrial Fibrillation: Understanding the New Oral Anticoagulants Dabigatran, Rivaroxaban, and Apixaban
Tang Kok Foo
Thrombosis, 2012
View PDFchevron_right
New Oral Anticoagulants in Atrial Fibrillation Forever?
Jeffrey Weitz
Circulation, 2013
View PDFchevron_right
New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation
GUALTIERO PALARETI
Journal of Internal Medicine, 2012
View PDFchevron_right
Emerging therapies for stroke prevention in atrial fibrillation
Jeffrey Weitz
European Heart Journal Supplements, 2005
View PDFchevron_right
Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
João Morais
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, 2016
View PDFchevron_right
Novel anticoagulants in atrial fibrillation stroke prevention
Nicholas Norgard
Therapeutic advances in chronic disease, 2012
View PDFchevron_right
New Anticoagulants for Atrial Fibrillation
Giulia Renda
Seminars in Thrombosis and Hemostasis, 2009
View PDFchevron_right
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
Gaetano Procaccianti
Italian Journal of Medicine, 2015
View PDFchevron_right
Dabigatran and other oral antithrombotic agents for the prevention of stroke in patients with atrial fibrillation
Fernando Testai
Research Reports in Clinical Cardiology, 2011
View PDFchevron_right
Stroke Prevention in Atrial Fibrillation: Current Status and Near-Future Directions
Sarah Hussain
The American Journal of Medicine, 2011
View PDFchevron_right
Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study
Graeme Hankey
American Heart Journal, 2010
View PDFchevron_right
Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation
Anil Chauhan
Postgraduate Medical Journal, 2005
View PDFchevron_right
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence
gerardo nigro
Therapeutic Advances in Drug Safety, 2016
View PDFchevron_right
Prevention of stroke in patients with atrial fibrillation: current strategies and future directions
Gabor Duray
European Heart Journal Supplements, 2008
View PDFchevron_right
Stroke Prevention in Atrial Fibrillation: Managing the Risks in Light of New Oral Anticoagulants
John Strobeck
Cardiovascular Drugs and Therapy, 2012
View PDFchevron_right
Novel antithrombotic agents for atrial fibrillation
Vias Markides, Diana Gorog
Pharmacology & Therapeutics, 2012
View PDFchevron_right
Dabigatran and Factor Xa Inhibitors for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
Masayasu Matsumoto
Journal of Stroke and Cerebrovascular Diseases, 2012
View PDFchevron_right
Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non–Vitamin K Antagonist Oral Anticoagulants
Joris Komen
Stroke, 2018
View PDFchevron_right
Newer Anticoagulants for Atrial Fibrillation: the Role of Dabigatran, Rivaroxaban, Apixaban and Edoxaban / RELY, ROCKET-AF, ARISTOTLE, & ENGAGE AF TIMI 48 Studies/ Safety Issues
Sokratis Pastromas
View PDFchevron_right
Anticoagulant Therapy in Atrial Fibrillation – Time for a Change?
Giulia Renda
European Cardiology Review, 2009
View PDFchevron_right
Antithrombotic Therapy for Atrial Fibrillation
Mark Eckman
Chest, 2012
View PDFchevron_right
Anticoagulation Strategies in Atrial Fibrillation
Sammy Khatib
Reviews in Cardiovascular Medicine, 2012
View PDFchevron_right
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy
Karin Wåhlander
Thrombosis Research, 2011
View PDFchevron_right
Relative effects of different non-vitamin K antagonist oral anticoagulants on global thrombotic status in atrial fibrillation
Mohamed Farag
Platelets, 2016
View PDFchevron_right
Antithrombotic therapy in nonvalvular atrial fibrillation: A narrative review
Francisco Rocha-Gonçalves
Revista Portuguesa de Cardiologia, 2011
View PDFchevron_right
Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Focus on Apixaban
Scott Yates
Advances in Therapy, 2012
View PDFchevron_right
Novel oral anticoagulants in atrial fibrillation: will the benefit outweigh the cost?
Athanasios Pipilis
Hellenic Journal of Cardiology, 2012
View PDFchevron_right
The Role of Nonvitamin K Antagonist Oral Anticoagulants (NOACs) in Stroke Prevention in Patients with Atrial Fibrillation
Can Gönen
Current neurology and neuroscience reports, 2016
View PDFchevron_right
Prevention of Stroke in Patients with Atrial Fibrillation: The Role of New Antiarrhythmic and Antithrombotic Drugs
Maciej Kluk
Cerebrovascular Diseases, 2010
View PDFchevron_right
Stroke Prevention Versus Bleeding Risk of Vitamin-K Antagonists: A Double-Edged Sword in Patients with Atrial Fibrillation Who Require Surgery
Dobromir Dobrev
Cardiovascular Therapeutics, 2009
View PDFchevron_right
Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents
Jean Pierre Bassand
Europace, 2012
View PDFchevron_right
Non-vitamin K antagonist anticoagulants to cardio embolic ischemic stroke due to atrial fibrillation: a brief update to clinical practice
Richard M . Montgomery
Perspectivas Médicas, 2016
View PDFchevron_right
Assessing Safety of Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors and Vitamin K Antagonists in Patients with Atrial Fibrillation: A Nation-Wide Propensity Score Matched Cohort from Sweden
Marie Linder
Clinical Epidemiology
View PDFchevron_right
Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
Jennifer Jeanne Vicera
IJC Heart & Vasculature, 2018
View PDFchevron_right